Schedule 13G ownership disclosure

ELEVATION ONCOLOGY INC

Common Stock · CUSIP: 28623U101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Logos Global Management LP

    Shares: 0.00 · Class: 0%

  • Logos Global Master Fund LP

    Shares: 0.00 · Class: 0%

  • Logos GP LLC

    Shares: 0.00 · Class: 0%

  • Arsani William

    Shares: 0.00 · Class: 0%

  • Logos Global Management GP LLC

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000168
Form type
SCHEDULE 13G/A
Filer
Elevation Oncology, Inc.
CIK
CIK 1783032
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub